Month: December 2023
SPONSORED CONTENT
The 340B drug pricing program allows covered entities serving vulnerable patient populations to buy medications at a discount. Since 1987, AIDS Healthcare Foundation has been on the frontline of the HIV response in the United States. AHF cares for patients regardless of their ability to pay. For AHF, 340B savings offset the costs of the critical services it provides to people living with HIV.
The 340B program transforms the healthcare landscape by leveling the playing field so providers can more effectively serve vulnerable communities. When individuals have access to affordable healthcare, they are more likely to seek necessary treatment and preventive services.
We will explore some key aspects of the 340B program with AHF Assistant Director of Prevention Jomil Luna. As a steadfast supporter of the 340B program, Jomil is a passionate public health and LGBTQ advocate in the New York community. He received his Master’s in Public Health from Rutgers University,
…SPONSORED CONTENT
After 30 years of serving vulnerable populations, the 340B Drug Pricing Program has grown considerably in scale and complexity. While it is arguably one of the most successful public/private partnerships in healthcare history, 340B is facing policy obstacles and headwinds that can make administering a program more challenging for covered entities than ever. This includes manufacturers limiting discounts to a single contract pharmacy and excluding high-cost drugs from the program. 340B administration is also complicated by perennial regulatory updates from CMS that impact the program directly and indirectly.
For these reasons and more, it can often make sense for covered entities to seek the expertise and assistance of a 340B vendor to reduce the complexity and optimize the savings from 340B. When you are working with partners, it’s important to ensure you are setting yourself up for success and the greatest return on your investment from the start. The implementation and onboarding process
…